These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8796607)
1. Functional computed tomography scanning with radiopaque agents: applications in the brain, kidney, and tumor of small and large mammals. Wolf GL; Gazelle GS; Hamberg L; Hunter G; Rogowska J; Jiang D; Leong F Acad Radiol; 1996 Aug; 3 Suppl 2():S376-8. PubMed ID: 8796607 [No Abstract] [Full Text] [Related]
2. Iopromide-carrying liposomes as a contrast agent for the liver. Krause W; Leike J; Schuhmann-Giampieri G; Sachse A; Schmiedl U; Strunk H Acad Radiol; 1996 Aug; 3 Suppl 2():S235-7. PubMed ID: 8796571 [No Abstract] [Full Text] [Related]
3. Use of iohexol clearance to determine the glomerular filtration rate. A comparison between different clearance techniques in man and animal. Frennby B Scand J Urol Nephrol Suppl; 1997; 182():1-63. PubMed ID: 9167229 [No Abstract] [Full Text] [Related]
4. Time course of biodistribution and changes in density following administration of iobitridol in rabbits. A comparative study vs iohexol. Rouleau P; Alison D; Bertrand P; Benderbous S; Havard P; Chambon C Acta Radiol Suppl; 1996; 400():49-55. PubMed ID: 8619352 [TBL] [Abstract][Full Text] [Related]
5. Contrast media clearance in a single kidney measured on multiphasic helical CT: results in 50 patients without acute renal disorder. Hackstein N; Cengiz H; Rau WS AJR Am J Roentgenol; 2002 Jan; 178(1):111-8. PubMed ID: 11756102 [TBL] [Abstract][Full Text] [Related]
6. Extrarenal plasma clearance of iohexol and other markers of normal and reduced glomerular filtration rate. Almén T; Frennby B; Sterner G; Chai CM; Jönsson BA; Månsson S Acad Radiol; 1996 Aug; 3 Suppl 2():S254-6. PubMed ID: 8796575 [No Abstract] [Full Text] [Related]
7. [Cerebral contrast medium extravasation after coronary angioplasty]. Foltys H; Krings T; Block F Nervenarzt; 2003 Oct; 74(10):892-5. PubMed ID: 14551695 [TBL] [Abstract][Full Text] [Related]
8. [Validity of iohexol clearance in chronic renal failure and in normal kidney function in comparison with 99mTc-DTPA clearance]. Mertz P Dtsch Med Wochenschr; 2003 Mar; 128(13):689-90; author reply 690. PubMed ID: 12660906 [No Abstract] [Full Text] [Related]
9. [Renal radionuclide scintigraphy in the evaluation of radiopaque substances on renal function]. Vesnina ZhV; Guliaev AM; Gol'tsov SG; Lishmanov IuB Vestn Rentgenol Radiol; 2007; (1):36-41. PubMed ID: 18274140 [TBL] [Abstract][Full Text] [Related]
10. Biliary and total extrarenal clearance of inulin and iohexol in pigs. A source of error when determining gfr as body clearance. van Westen D; Almén T; Chai CM; Frennby B; Månsson S; Sterner G Nephron; 2002 Jun; 91(2):300-7. PubMed ID: 12053069 [TBL] [Abstract][Full Text] [Related]
11. Biliary excretion and biliary clearance from plasma of lohexol in normal and nephrectomized pigs. Almén TH; van Westen D; Frennby B; Sterner G; Chai CM; Månsson SA Acad Radiol; 2002 May; 9 Suppl 1():S58-61. PubMed ID: 12019896 [No Abstract] [Full Text] [Related]
12. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol. Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130 [TBL] [Abstract][Full Text] [Related]
13. Development of biodegradable ioxilan carbonate particles for contrast enhancement of the liver in computed tomography scanning: toxicity assessment. Li C; McCuskey P; Yang DJ; Kan Z; Wallace S Acad Radiol; 1996 Aug; 3 Suppl 2():S227-8. PubMed ID: 8796568 [No Abstract] [Full Text] [Related]
14. Elimination of low-osmolality contrast media by hemodialysis. Furukawa T; Ueda J; Takahashi S; Sakaguchi K Acta Radiol; 1996 Nov; 37(6):966-71. PubMed ID: 8995475 [TBL] [Abstract][Full Text] [Related]
15. [Permeability disorders of the blood-brain barrier following intravascular contrast medium administration in kidney failure]. Knof J; Pommer W; Kern D Rofo; 1992 Jan; 156(1):103-5. PubMed ID: 1733468 [No Abstract] [Full Text] [Related]
16. Visualizing renal anatomy and function with 1-10,000-nm radiocontrast agents. Wolf GL; Rogowska J; Bessin G; Trocha M; Whiteman K; Wolf D; Shore MT Acad Radiol; 1998 Apr; 5 Suppl 1():S127-30; discussion S131-2. PubMed ID: 9561062 [No Abstract] [Full Text] [Related]
17. Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles. Wisner ER; Katzberg RW; Griffey SM; Haley PJ; Johnson DK; Vessey AR Acad Radiol; 1996 Aug; 3 Suppl 2():S257-60. PubMed ID: 8796576 [No Abstract] [Full Text] [Related]
18. Dynamic contrast-enhanced computed tomography to assess antitumor treatment effects: comparison of two contrast agents with different pharmacokinetics. Jost G; Pietsch H; Grenacher L Invest Radiol; 2013 Oct; 48(10):715-21. PubMed ID: 23666093 [TBL] [Abstract][Full Text] [Related]
19. The impact of the viscosity and osmolality of iodine contrast agents on renal elimination. Jost G; Pietsch H; Lengsfeld P; Hütter J; Sieber MA Invest Radiol; 2010 May; 45(5):255-61. PubMed ID: 20375847 [TBL] [Abstract][Full Text] [Related]
20. Clearance of iohexol, chromium-51-ethylenediaminetetraacetic acid, and creatinine for determining the glomerular filtration rate in pigs with normal renal function: comparison of different clearance techniques. Frennby B; Sterner G; Almén T; Chai CM; Jönsson BA; Månsson S Acad Radiol; 1996 Aug; 3(8):651-9. PubMed ID: 8796729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]